Investors' Attys Seek $29M Cut Of Novo Nordisk Deal
Attorneys for investors in Danish pharmaceutical giant Novo Nordisk have requested nearly a third of a $100 million settlement that, if approved, would resolve claims the company hurt shareholders by failing...To view the full article, register now.
Already a subscriber? Click here to view full article